Virios Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VIRI and buy or sell other stocks, ETFs, and their options commission-free!About VIRI
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron.
CEOGregory Duncan, MBA
CEOGregory Duncan, MBA
Employees12
Employees12
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
Founded
Employees12
Employees12
VIRI Key Statistics
Market cap8.89M
Market cap8.89M
Price-Earnings ratio-0.26
Price-Earnings ratio-0.26
Dividend yield—
Dividend yield—
Average volume45.42K
Average volume45.42K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$29.28
52 Week high$29.28
52 Week low$1.87
52 Week low$1.87
Stock Snapshot
With a market cap of 8.89M, Virios Therapeutics(VIRI) trades at $3.88. The stock has a price-to-earnings ratio of -0.26.
Virios Therapeutics(VIRI) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Virios Therapeutics(VIRI) shares are trading with a volume of 0, against a daily average of 45.42K.
In the last year, Virios Therapeutics(VIRI) shares hit a 52-week high of $29.28 and a 52-week low of $1.87.
In the last year, Virios Therapeutics(VIRI) shares hit a 52-week high of $29.28 and a 52-week low of $1.87.
People also own
Based on the portfolios of people who own VIRI. This list is generated using Robinhood data, and it’s not a recommendation.